EXS-29787-75817 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-28
Registered in v-safe
2021-09-28
Dose 1 — Pfizer-BioNTech
2021-09-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-09-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-10-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-10-19
Dose 2 — Pfizer-BioNTech
2021-10-21
Survey response — days 1–6 daily, dose 2
MedDRA: Chills, Dizziness, Mobility decreased, Pain in extremity, Pain of skin — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Painful hands and feet, painful skin on scalp, dizziness, shivering, unable to sit up for long periods of time

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-28	Pfizer-BioNTech	No
2	2021-10-19	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 2

2021-10-21

Systemic reaction (other): Painful hands and feet, painful skin on scalp, dizziness, shivering, unable to sit up for long periods of time

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Chills	·	·	✓
SRO	Dizziness	·	·	✓
SRO	Mobility decreased	·	·	✓
SRO	Pain in extremity	·	·	✓
SRO	Pain of skin	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release